Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegfilgrastim versus filgrastim after autologous peripheral blood stem cell transplantation in lymphoma or myeloma
2008-002138-31Phase 2Completed
- Sponsor
- Centre Léon Bérard
- Start
- Aug 2008
- Modality
- Recombinant Proteins and Enzymes, Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in multiple myeloma (MM) and lymphoma comparing Pegfilgrastim arm with Filgrastim arm (2 arms). Primary endpoint: Days of febrile neutropenia. Started Aug 2008; status: completed.
02
Drugs
pegfilgrastimfilgrastim
03
Conditions
multiple myeloma (MM)lymphoma
Beyond the preview
Go deeper on 2008-002138-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002138-31.